TCGX Acquisition II, a blank check company formed by TCGX executives targeting healthcare in Asia, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
The company plans to raise $100 million by offering 10 million units at $10. Unlike most SPACs, TCGX Acquisition II did not offer units with warrants or rights attached.
TCGX Acquisition II is led by CEO and Director Chen Yu, the founder and Managing Member of TCG Crossover (TCGX). He is joined by CFO and Director Craig Skaling, the CFO and COO of TCGX. Their previous SPAC, TCGX Acquisition (TCGX; +41% from $10 offer price), went public in August 2026 and is targeting healthcare in Asia. TCGX Acquisition II also intends to target life sciences and medical technology sectors in Asia.
The Palo Alto, CA-based company was founded in 2026. It plans to list on the Nasdaq under the symbol TCXB. Guggenheim Securities is the sole bookrunner on the deal.
